Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2025-12-24 @ 11:14 PM
NCT ID:
NCT07285356
Eligibility Criteria:
Inclusion Criteria:
* Patients aged 18 years or older who have provided written informed consent.
* Colon adenocarcinoma with high-risk stage III (pT4pN2) or stage IV.
* Oxaliplatin-based treatment in the context of localized or metastatic disease.
* Eastern Cooperative Oncology Group (ECOG) performance status of 0-1.
Exclusion Criteria:
* Pre-existing neuropathy.
* Uncontrolled diabetes.
* known glove allergies.
* Prior treatment with paclitaxel, docetaxel or oxaliplatin.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07285356
Study Brief:
Protocol Section:
NCT07285356